DUBLIN–(BUSINESS WIRE)–The “Top
50 Company Research Reports for Pharmaceuticals & Biotechnology”
company profile has been added to ResearchAndMarkets.com’s
offering.
Top 50 Report for the Pharmaceuticals & Biotechnology Industry (Global)
contains a comprehensive PDF report for each of the top 50 companies in
the industry (ranked by sales or revenue).
These fundamental data reports are derived from the Worldscope Database
which covers over 98% of the world’s market capitalization and
represents the leading public companies in over 100 countries. The
proprietary Publisher’s Quality Rating – a measure of corporate risk –
is assigned to each company.
Research Report Users:
Investment professionals; corporate users: finance, marketing, business
development; academics and researchers
Product Features:
-
Timely and accurate information on the leading companies in the global
industry -
Unified Format across the world (consistent format for all companies
and countries) - Deep research content (up to 10-years of historical analysis)
- Broad base of research (up to 40 unique sub-reports on each company)
-
Proprietary Publisher’s Quality Rating (provides a measure of
corporate risk) -
Deeply discounted price of bundled industry reports – compared to
purchase of individual company reports. -
Report Content: (The following description applies to each of the 50
company reports that are included in the Top50 product). Two
descriptive formats are presented; an Abstract and a more extensive
Synopsis.
Abstract:
A textual analysis of the financial results compared to selected
competitors. Also included are quantitative analyses of the company’s
financial statements, extensive ratio analyses and up to 10-year history
of sales, earnings, dividends and security pricing. A business
description of the company, including contact information, senior
officers and Publisher’s Quality Rating analyses is also provided. Also
included, as part of each company report, is extensive industry averages
for financial ratios and key ratio data to which the company results can
be compared.
Also included, as part of each company report, are extensive industry
average reports for financial statements and key ratio reports to which
the company results can be compared.
Key Topics Covered:
Section 1:
- Company Fundamentals
- Report: Company Profile
- Comparative Business Analysis
- Summary Analysis
- Sales Analysis
- Price Analysis
- Earnings & Dividends Analysis
Section 2:
- Financial Statement Analyses
- Report: Balance Sheet – Annual
- Balance Sheet – Annual – Common Size
- Balance Sheet – Annual – Year-Year % Change
- Balance Sheet – Annual – Five-Year Averages
- Balance Sheet – Interim
- Balance Sheet – Interim – Common Size
- Income Statement – Annual
- Income Statement – Annual – Common Size
- Income Statement – Year-Year % Change
- Income Statement – Five-Year Averages
- Income Statement – Interim
- Income Statement – Interim – Common Size
- Sources of Capital – Net Change
Section 3:
- Financial Ratio Analyses
- Report: Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Ratios
- Profitability Analysis
Section 4:
- Publisher’s Quality Rating Analyses
- Report: Investment Acceptance
- Financial Strength
- Profitability & Stability
- Corporate Growth
Section 5:
- Industry Overview
- Report: Publisher’s Industry Averages – Overview
Section 6:
- Industry Financial Statement Analyses
- Report: Summary Analysis
- Sales Analysis
- Income Statement
- Balance Sheet
- Sources of Capital
Section 7:
- Industry Financial Ratio Analyses
- Report: Leverage Analysis
- Per-Share Data
- Profitability Analysis
Section 8:
- Publisher Quality Rating Overview
- Report: Explanation of the Publisher’s Quality Rating
Companies Mentioned
- Johnson & Johnson
- Roche Holding Aktiengesellschaft
- Pfizer Inc.
- Novartis AG
- Bayer AG
- Sanofi S.A.
- Merck & Co. Inc.
- GlaxoSmithKline plc
- Abbvie Inc
- Abbott Laboratories
- Gilead Sciences Inc.
- Eli Lilly and Company
- China Resources Pharmaceutical Group Ltd
- Amgen Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Limited
- Bristol-Myers Squibb Company
- Takeda Pharmaceutical Company Limited
- Merck KGaA
- Novo Nordisk As
- Allergan plc
- Celgene Corporation
- Biogen Inc
- Astellas Pharma Incorporated
- Mylan NV
- Otsuka Holdings Company Limited
- Daiichi Sankyo Company Limited
- Bausch Health Companies Inc
- CSL Limited
- Regeneron Pharmaceuticals Incorporated
- Guangzhou Baiyunshan Pharmceutical Holdings Co Ltd
- Zoetis Inc
- Eisai Company Limited
- Lonza Group AG
- Shenzhen Neptunus Bioengineer
- UCB Sa
- Chugai Pharmaceutical Co Ltd
- Grifols SA
- Perrigo Company PLC
- Sun Pharmaceuticals Industries Ltd
- Nanjing Pharmaceutical Company Limited
- Protek PAO
- Sumitomo Dainippon Pharma Co Ltd
- Alexion Pharmaceuticals Inc.
- Mitsubishi Tanabe Pharma Corp
- Kangmei Pharmaceutical Co Ltd
- Shanghai Fosun Pharmaceutical (Group) Company Limited
- Endo International PLC
- Shionogi & Co Ltd
- Mallinckrodt PLC
For more information about this company profile visit https://www.researchandmarkets.com/r/pfy4w5
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Company
Reports